Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
388
NCT05036135
A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)
Phase: Phase 2/3
Role: Lead Sponsor
Start: Dec 2, 2021
Completion: Aug 9, 2024
NCT05557942
Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)
Phase: Phase 3
Start: Nov 2, 2022
Completion: Aug 8, 2024